White label ELPA - ClinicalTrials.eu

Study of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer

Not recruiting

3 1 1
Investigated Diseases:
- Ovarian low malignant potential tumour
Investigated Drugs:
- Catequentinib Dihydrochloride
Study of Monalizumab and Volrustomig for Patients with MSI and/or dMMR Metastatic Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Microsatellite instability cancer
Investigated Drugs:
- Monalizumab
- Volrustomig
Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Oxygen
Study on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Endometrial cancer stage II
- Endometrial cancer stage I
Investigated Drugs:
- Tilmanocept
- Gallium (68Ga) Chloride
Study of Trifluridine and Tipiracil in Patients with ER-Positive, HER2-Negative Advanced Breast Cancer After Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Tipiracil Hydrochloride
- Trifluridine
Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

Not recruiting

3 1 1
Investigated Diseases:
- Prophylaxis of nausea and vomiting
Investigated Drugs:
- Aprepitant
- Fosaprepitant
Study on the Safety of Low-Dose Cytarabine or Azacitidine with Venetoclax and Quizartinib for Acute Myeloid Leukemia in Patients Aged 60+ Ineligible for Standard Chemotherapy

Not recruiting

1 1 1 1
Investigated Drugs:
- Quizartinib Dihydrochloride
- Venetoclax
Study on Tranexamic Acid for Reducing Blood Loss in Osteoarthritis Patients Undergoing Total Hip Replacement

Not recruiting

2 1 1 1
Investigated Drugs:
- Tranexamic Acid
Study on the Safety and Effectiveness of Melatonin and Ocrelizumab for Patients with Primary Progressive Multiple Sclerosis

Not recruiting

2 1 1
Investigated Diseases:
- Primary progressive multiple sclerosis
Investigated Drugs:
Study of L19IL2 and L19TNF for Patients with Advanced Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma Not Eligible for Surgery or Radiation

Not recruiting

2 1 1
Investigated Diseases:
- Basal cell carcinoma
- Squamous cell carcinoma of skin
Investigated Drugs:
- Bifikafusp Alfa
- Onfekafusp Alfa

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies